Phytochemicals intended for anticancer effects at preclinical levels to clinical practice: Assessment of formulations at nanoscale for non-small cell lung cancer (NSCLC) therapy

作者: Vinoth Kumar Ponnusamy , Arivalagan Pugazhendhi , Arivalagan Pugazhendhi , Kathirvel Brindhadevi , V. Bharath Kumar

DOI: 10.1016/J.PROCBIO.2021.02.004

关键词: Review articleClinical trialnon-small cell lung cancer (NSCLC)MedicineInternal medicineHigh dosesCancerOncologyPhytochemicalNon small cellClinical Practice

摘要: Abstract Over the past few decades, many of phytochemicals have been shown to possess extraordinary anticancer effects, clinical tested, approved as drugs, and currently in use. A considerable number either a single-agent or combined with existing drugs at pre-clinical levels evaluated date. However, trials on phytochemical evaluations against world's top-ranked cancer, NSCLC, was found be very little. Some that showed significant activity NSCLC vitro and/or vivo preclinical are highlighted this review article. There several impediments such poor solubility, bioavailability, low stability, requirement high doses, safety toxicity limits wide-spread use oncology. Nanotherapeutic systems can help overcome aforementioned issues wide open gates focus phyto-oncotherapy, particular NSCLC. The current aims summarize importance agents, special mention nano-formulations treat non-small cell lung cancer (NSCLC).

参考文章(258)
Priyanka P. Brahmkshatriya, Pathik S. Brahmkshatriya, Terpenes: Chemistry, Biological Role, and Therapeutic Applications Springer Berlin Heidelberg. pp. 2665- 2691 ,(2013) , 10.1007/978-3-642-22144-6_120
Madan Jagasia, Hak Choy, David H. Johnson, Furhan Yunus, Russell F. Devore, Kenneth R. Hande, John R. Roberts, Anuradha Chakravarthy, Weekly irinotecan and concurrent radiation therapy for stage III unresectable NSCLC. Oncology. ,vol. 14, pp. 43- 46 ,(2000)
Jean-Paul Sculier, Anne-Pascale Meert, Thierry Berghmans, Nathalie Leclercq, Arnaud Scherpereel, Marianne Paesmans, Jacques Lecomte, Jean-Jacques Lafitte, Vicente Giner Marco, An ELCWP Phase III Trial Comparing Ifosfamide and Cisplatin Regimens in Advanced NSCLC Anticancer Research. ,vol. 33, pp. 5477- 5482 ,(2013)
Ui-Jin Bae, Mi-Young Song, Hyun-Young Jang, Jung Min Lim, So Yoon Lee, Jae-Ha Ryu, Byung-Hyun Park, Emodin isolated from Rheum palmatum prevents cytokine-induced β-cell damage and the development of type 1 diabetes Journal of Functional Foods. ,vol. 16, pp. 9- 19 ,(2015) , 10.1016/J.JFF.2015.04.016
Zhong-Wen Yuan, Elaine Lai-Han Leung, Xing-Xing Fan, Hua Zhou, Wen-Zhe Ma, Liang Liu, Ying Xie, Quantitative evaluation of berberine subcellular distribution and cellular accumulation in non-small cell lung cancer cells by UPLC-MS/MS. Talanta. ,vol. 144, pp. 20- 28 ,(2015) , 10.1016/J.TALANTA.2015.05.017
Chi-Yuan Chen, Zhu-Yun Yu, Yen-Shu Chuang, Rui-Mei Huang, Tzu-Chien V Wang, Sulforaphane attenuates EGFR signaling in NSCLC cells Journal of Biomedical Science. ,vol. 22, pp. 38- 38 ,(2015) , 10.1186/S12929-015-0139-X
Cristina Andrs-Lacueva, Alex Medina-Remon, Rafael Llorach, Mireia Urpi-Sarda, Nasiruddin Khan, Gemma Chiva-Blanch, Raul Zamora-Ros, Maria Rotches-Ribalta, Rosa M. Lamuela-Ravents, Phenolic Compounds: Chemistry and Occurrence in Fruits and Vegetables Fruit and Vegetable Phytochemicals. pp. 53- 88 ,(2009) , 10.1002/9780813809397.CH2
Michelle G. Lihou, Yaw-Huei Hsiang, Leroy F. Liu, Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin Cancer Research. ,vol. 49, pp. 5077- 5082 ,(1989)
Zhuan Hong, Xiang Cao, Na Li, Yizhou Zhang, Lei Lan, Yi Zhou, Xiaolong Pan, Lei Shen, Zhimin Yin, Lan Luo, Luteolin is effective in the non‐small cell lung cancer model with L858R/T790M EGF receptor mutation and erlotinib resistance British Journal of Pharmacology. ,vol. 171, pp. 2842- 2853 ,(2014) , 10.1111/BPH.12610
Wei Zhong, Mengzhao Wang, Yan Xu, Jing Zhao, Yang Zhou, Combined Chemotherapy with Vinorelbine and Ifosfamide as Third-line Treatment and Beyond of Advanced Non-small Cell Lung Cancer Chinese journal of lung cancer. ,vol. 18, pp. 351- 357 ,(2015) , 10.3779/J.ISSN.1009-3419.2015.06.04